BioStem Technologies, Inc. Common Stock (BSEM)

BioStem Technologies, Inc. Common Stock Stock (BSEM) Financials Data

*All numbers in millions

Period End Date	2026-06-30
Period Length	3 Months
Revenues	7.90
Cost Of Revenue	3.06
Gross Profit	4.84
	13.24
Research and Development	0.73
Depreciation and Amortization	0.69
Operating Income/Loss	-8.40
Nonoperating Income/Loss	-0.57
Income/Loss From Continuing Operations Before Tax	-8.97
Income Tax Expense/Benefit	-
	-8.97
Attributable To Parent	-8.97
Basic Average Shares	17.33
Diluted Average Shares	17.33
Basic Earnings Per Share	-0.52
Diluted Earnings Per Share	-0.52